Veebot
Private Company
Funding information not available
Overview
Veebot is a private, pre-revenue medical device company pioneering robotic needle insertion for vascular access and biopsy procedures. The company has developed a working prototype with demonstrated success in over 25 insertions and holds key intellectual property with multiple patents. Targeting the vast market of manual needle insertions, Veebot's solution promises greater accuracy, reduced pain, and the potential to expand care settings. Its success hinges on clinical validation, regulatory clearance, and achieving commercial scale in a competitive medtech landscape.
Technology Platform
Autonomous robotic system integrating real-time image guidance (e.g., ultrasound) and computer vision for precise needle insertion.
Opportunities
Risk Factors
Competitive Landscape
Veebot operates in the emerging field of robotic vascular access, competing with other startups like Vitestro (Europe) and VascuLogic. It also faces indirect competition from advanced handheld ultrasound-guided devices and the entrenched standard of care: manual insertion by phlebotomists and nurses. Large medical device companies may enter the space through acquisition or internal development.